TSND Stock Overview
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 1/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
TerrAscend Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.93 |
52 Week High | CA$3.21 |
52 Week Low | CA$0.73 |
Beta | 1.81 |
1 Month Change | -12.26% |
3 Month Change | -44.64% |
1 Year Change | -54.63% |
3 Year Change | -88.24% |
5 Year Change | -61.41% |
Change since IPO | -23.14% |
Recent News & Updates
Recent updates
Is TerrAscend (TSE:TSND) A Risky Investment?
Sep 03TerrAscend (TSE:TSND) Takes On Some Risk With Its Use Of Debt
Apr 25What You Can Learn From TerrAscend Corp.'s (TSE:TSND) P/SAfter Its 25% Share Price Crash
Mar 10Revenues Tell The Story For TerrAscend Corp. (TSE:TSND) As Its Stock Soars 25%
Jan 24Is TerrAscend (TSE:TSND) A Risky Investment?
Dec 25TerrAscend (TSE:TSND) Is Carrying A Fair Bit Of Debt
Aug 13TerrAscend Corp.'s (CSE:TER) Earnings Haven't Escaped The Attention Of Investors
Jul 03TerrAscend (CSE:TER) Is Making Moderate Use Of Debt
Mar 06Is There An Opportunity With TerrAscend Corp.'s (CSE:TER) 37% Undervaluation?
Dec 21Some Analysts Just Cut Their TerrAscend Corp. (CSE:TER) Estimates
Aug 14Is TerrAscend (CSE:TER) Using Too Much Debt?
Jul 15Shareholder Returns
TSND | CA Pharmaceuticals | CA Market | |
---|---|---|---|
7D | 6.9% | -0.5% | -2.6% |
1Y | -54.6% | -26.7% | 15.2% |
Return vs Industry: TSND underperformed the Canadian Pharmaceuticals industry which returned -26.7% over the past year.
Return vs Market: TSND underperformed the Canadian Market which returned 15.2% over the past year.
Price Volatility
TSND volatility | |
---|---|
TSND Average Weekly Movement | 15.3% |
Pharmaceuticals Industry Average Movement | 12.0% |
Market Average Movement | 8.2% |
10% most volatile stocks in CA Market | 17.4% |
10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: TSND's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: TSND's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2017 | 1,055 | Ziad Ghanem | www.terrascend.com |
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.
TerrAscend Corp. Fundamentals Summary
TSND fundamental statistics | |
---|---|
Market cap | CA$330.87m |
Earnings (TTM) | -CA$132.96m |
Revenue (TTM) | CA$458.26m |
0.6x
P/S Ratio-2.0x
P/E RatioIs TSND overvalued?
See Fair Value and valuation analysisEarnings & Revenue
TSND income statement (TTM) | |
---|---|
Revenue | US$318.89m |
Cost of Revenue | US$164.49m |
Gross Profit | US$154.40m |
Other Expenses | US$246.92m |
Earnings | -US$92.52m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.32 |
Gross Margin | 48.42% |
Net Profit Margin | -29.01% |
Debt/Equity Ratio | 96.0% |
How did TSND perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 21:51 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
TerrAscend Corp. is covered by 15 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Frederico Yokota Choucair Gomes | ATB Capital Markets |
Kenric Tyghe | ATB Capital Markets |
Shaan Mir | Canaccord Genuity |